IS8007A - 4-(2-fenýlsúlfanýl-fenýl)-1,2,3,6-tetrahýdrópýridín afleiður sem serótónín endurupptöku hindrar - Google Patents
4-(2-fenýlsúlfanýl-fenýl)-1,2,3,6-tetrahýdrópýridín afleiður sem serótónín endurupptöku hindrarInfo
- Publication number
- IS8007A IS8007A IS8007A IS8007A IS8007A IS 8007 A IS8007 A IS 8007A IS 8007 A IS8007 A IS 8007A IS 8007 A IS8007 A IS 8007A IS 8007 A IS8007 A IS 8007A
- Authority
- IS
- Iceland
- Prior art keywords
- phenylsulfanyl
- phenyl
- serotonin reuptake
- inhibit serotonin
- tetrahydropyridine derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/70—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Anesthesiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DKPA200300518 | 2003-04-04 | ||
| PCT/DK2004/000243 WO2004087662A1 (en) | 2003-04-04 | 2004-04-02 | 4-(2-phenylsulfanyl-phenyl)-1,2,3,6-tetrahydropyridine derivatives as serotonin reuptake inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IS8007A true IS8007A (is) | 2005-08-29 |
Family
ID=35432910
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IS8007A IS8007A (is) | 2003-04-04 | 2005-08-29 | 4-(2-fenýlsúlfanýl-fenýl)-1,2,3,6-tetrahýdrópýridín afleiður sem serótónín endurupptöku hindrar |
Country Status (27)
| Country | Link |
|---|---|
| US (1) | US20070173522A1 (is) |
| EP (1) | EP1613594B1 (is) |
| JP (1) | JP2006522029A (is) |
| KR (1) | KR20060021825A (is) |
| CN (1) | CN100384822C (is) |
| AR (1) | AR043964A1 (is) |
| AT (1) | ATE390413T1 (is) |
| AU (1) | AU2004226319A1 (is) |
| BR (1) | BRPI0408453A (is) |
| CA (1) | CA2521172A1 (is) |
| CL (1) | CL2004000730A1 (is) |
| CO (1) | CO5700777A2 (is) |
| DE (1) | DE602004012724T2 (is) |
| DK (1) | DK1613594T3 (is) |
| EA (1) | EA009282B1 (is) |
| ES (1) | ES2301979T3 (is) |
| HR (1) | HRP20080243T3 (is) |
| IS (1) | IS8007A (is) |
| MX (1) | MXPA05010678A (is) |
| NO (1) | NO20055205L (is) |
| NZ (1) | NZ541944A (is) |
| PL (1) | PL1613594T3 (is) |
| PT (1) | PT1613594E (is) |
| SI (1) | SI1613594T1 (is) |
| UA (1) | UA81300C2 (is) |
| WO (1) | WO2004087662A1 (is) |
| ZA (1) | ZA200507182B (is) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HRP20080478T3 (hr) | 2003-04-04 | 2009-02-28 | H. Lundbeck A/S | Derivati 4-(2-fenilsulfanil-fenil)-piperidina kaoinhibitori ponovne pohrane serotonina |
| US8685924B2 (en) | 2004-08-25 | 2014-04-01 | Takeda Pharmaceutical Company Limited | Preventives/remedies for stress urinary incontinence and method of screening the same |
| EP2018863B9 (en) | 2006-05-16 | 2015-02-18 | Takeda Pharmaceutical Company Limited | Fused heterocyclic compound and use thereof |
| EP2789338A3 (en) | 2007-11-15 | 2015-01-14 | Takeda Pharmaceutical Company Limited | Condensed pyridine derivate and use thereof |
| UA98698C2 (en) * | 2008-03-03 | 2012-06-11 | Х. Луннбек А/С | Phenylsulfanylphenyl-piperidines and process for the preparation thereof |
| US20120253036A1 (en) | 2009-12-11 | 2012-10-04 | Yukinori Nagakura | Agent for treating fibromyalgia |
| EP2930171A1 (en) * | 2014-04-07 | 2015-10-14 | LEK Pharmaceuticals d.d. | Synthesis of vortioxetine via (2,4-dimethylphenyl)(2-iodophenyl)sulfane intermediate |
| CN105294554B (zh) * | 2015-11-18 | 2017-11-07 | 乳源瑶族自治县大众药品贸易有限公司 | 苯基哌嗪衍生物及其使用方法和用途 |
| US20210052600A1 (en) | 2017-12-27 | 2021-02-25 | Takeda Pharmaceutical Company Limited | Therapeutic agents for stress urinary incontinence and incotinence of feces |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3803143A (en) * | 1969-09-08 | 1974-04-09 | Eisai Co Ltd | 6-amino alkylene 6,7-dihydro-5h-dibenzo (b,g),(1,5)thiazocines |
| US4018830A (en) * | 1969-09-22 | 1977-04-19 | Merck & Co., Inc. | Phenylthioaralkylamines |
| US4055665A (en) * | 1974-11-25 | 1977-10-25 | Merck & Co., Inc. | Treating arrythmia with phenylthioaralkylamines |
| US4066654A (en) * | 1975-04-16 | 1978-01-03 | G. D. Searle & Co. | 1-triarylalkyl-4-phenyl-4-piperidine carboxylic acids and derivatives |
| US4056632A (en) * | 1975-07-21 | 1977-11-01 | Burroughs Wellcome Co. | 2-Hydroxymethyl-2'-aminomethyl-diphenylsulfides and method of use |
| US4241071A (en) * | 1977-01-27 | 1980-12-23 | American Hoechst Corporation | Antidepressant (α-phenyl-2-tolyl)azacycloalkanes |
| DE2802306A1 (de) * | 1977-01-27 | 1978-08-10 | Hoechst Ag | Azacycloalkane, azacycloalkene und ihre derivate |
| US4198419A (en) * | 1979-01-10 | 1980-04-15 | American Hoechst Corporation | Phenylthiophenylpiperidines |
| US4198417A (en) * | 1979-01-10 | 1980-04-15 | American Hoechst Corporation | Phenoxyphenylpiperidines |
| GB8912971D0 (en) * | 1989-06-06 | 1989-07-26 | Wellcome Found | Halogen substituted diphenylsulfides |
| US6410736B1 (en) * | 1999-11-29 | 2002-06-25 | Pfizer Inc. | Biaryl ether derivatives useful as monoamine reuptake inhibitors |
| WO2001027068A1 (en) * | 1999-10-13 | 2001-04-19 | Pfizer Products Inc. | Biaryl ether derivatives useful as monoamine reuptake inhibitors |
| PL199351B1 (pl) * | 1999-12-30 | 2008-09-30 | Lundbeck & Co As H | Związki pochodne fenylopiperazyny, zawierająca je kompozycja farmaceutyczna i ich zastosowanie |
| US6436938B1 (en) * | 2001-01-22 | 2002-08-20 | Pfizer Inc. | Combination treatment for depression |
| US20020107244A1 (en) * | 2001-02-02 | 2002-08-08 | Howard Harry R. | Combination treatment for depression |
| UA81749C2 (uk) * | 2001-10-04 | 2008-02-11 | Х. Луннбек А/С | Фенілпіперазинові похідні як інгібітори зворотного захоплення серотоніну |
-
2004
- 2004-02-04 UA UAA200508779A patent/UA81300C2/uk unknown
- 2004-04-02 NZ NZ541944A patent/NZ541944A/en unknown
- 2004-04-02 SI SI200430727T patent/SI1613594T1/sl unknown
- 2004-04-02 AR ARP040101130A patent/AR043964A1/es not_active Application Discontinuation
- 2004-04-02 CN CNB2004800094713A patent/CN100384822C/zh not_active Expired - Fee Related
- 2004-04-02 CL CL200400730A patent/CL2004000730A1/es unknown
- 2004-04-02 WO PCT/DK2004/000243 patent/WO2004087662A1/en not_active Ceased
- 2004-04-02 ES ES04725299T patent/ES2301979T3/es not_active Expired - Lifetime
- 2004-04-02 CA CA002521172A patent/CA2521172A1/en not_active Abandoned
- 2004-04-02 PL PL04725299T patent/PL1613594T3/pl unknown
- 2004-04-02 HR HR20080243T patent/HRP20080243T3/xx unknown
- 2004-04-02 KR KR1020057018870A patent/KR20060021825A/ko not_active Withdrawn
- 2004-04-02 US US10/551,869 patent/US20070173522A1/en not_active Abandoned
- 2004-04-02 AU AU2004226319A patent/AU2004226319A1/en not_active Abandoned
- 2004-04-02 EA EA200501579A patent/EA009282B1/ru not_active IP Right Cessation
- 2004-04-02 ZA ZA200507182A patent/ZA200507182B/en unknown
- 2004-04-02 DK DK04725299T patent/DK1613594T3/da active
- 2004-04-02 BR BRPI0408453-5A patent/BRPI0408453A/pt not_active IP Right Cessation
- 2004-04-02 PT PT04725299T patent/PT1613594E/pt unknown
- 2004-04-02 DE DE602004012724T patent/DE602004012724T2/de not_active Expired - Fee Related
- 2004-04-02 JP JP2006504348A patent/JP2006522029A/ja active Pending
- 2004-04-02 AT AT04725299T patent/ATE390413T1/de not_active IP Right Cessation
- 2004-04-02 EP EP04725299A patent/EP1613594B1/en not_active Expired - Lifetime
- 2004-04-02 MX MXPA05010678A patent/MXPA05010678A/es active IP Right Grant
-
2005
- 2005-08-29 IS IS8007A patent/IS8007A/is unknown
- 2005-11-02 CO CO05111852A patent/CO5700777A2/es unknown
- 2005-11-04 NO NO20055205A patent/NO20055205L/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MXPA05010678A (es) | 2005-12-12 |
| AR043964A1 (es) | 2005-08-17 |
| CO5700777A2 (es) | 2006-11-30 |
| SI1613594T1 (sl) | 2008-08-31 |
| EA009282B1 (ru) | 2007-12-28 |
| NO20055205L (no) | 2005-11-04 |
| EP1613594A1 (en) | 2006-01-11 |
| ZA200507182B (en) | 2006-12-27 |
| WO2004087662A1 (en) | 2004-10-14 |
| BRPI0408453A (pt) | 2006-04-04 |
| AU2004226319A1 (en) | 2004-10-14 |
| CL2004000730A1 (es) | 2005-02-18 |
| UA81300C2 (en) | 2007-12-25 |
| HRP20080243T3 (hr) | 2009-04-30 |
| JP2006522029A (ja) | 2006-09-28 |
| ES2301979T3 (es) | 2008-07-01 |
| PT1613594E (pt) | 2008-07-01 |
| KR20060021825A (ko) | 2006-03-08 |
| HK1090051A1 (en) | 2006-12-15 |
| DK1613594T3 (da) | 2008-07-14 |
| CN100384822C (zh) | 2008-04-30 |
| PL1613594T3 (pl) | 2008-09-30 |
| DE602004012724D1 (de) | 2008-05-08 |
| DE602004012724T2 (de) | 2009-04-09 |
| CN1777585A (zh) | 2006-05-24 |
| NZ541944A (en) | 2008-05-30 |
| US20070173522A1 (en) | 2007-07-26 |
| ATE390413T1 (de) | 2008-04-15 |
| CA2521172A1 (en) | 2004-10-14 |
| EP1613594B1 (en) | 2008-03-26 |
| EA200501579A1 (ru) | 2006-04-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60233608D1 (de) | Phenylpiperidinderivate als Serotonin-Wiederaufnahmehemmer | |
| HUS1900034I1 (hu) | 6,7-telítetlen-7-karbamoil-szubsztituált morfinán-származékok | |
| IS6704A (is) | Fenoxýbensýlamínafleiður sem valvísir serótónín endurupptöku hindrar | |
| ATE292128T1 (de) | Piperidinderivate als neurokinin 1 antagonisten | |
| ZA200610666B (en) | Piperidine derivatives as NK, antagonists | |
| NO20054607D0 (no) | Nitrogenholdig heterosyklisk derivat som har 2,6-disubstituert styryl | |
| IS8007A (is) | 4-(2-fenýlsúlfanýl-fenýl)-1,2,3,6-tetrahýdrópýridín afleiður sem serótónín endurupptöku hindrar | |
| DE602004010385D1 (de) | 3,4-disubstituierte 1,2,3,4-tetrahydropyridinderivate | |
| DK1656305T3 (da) | Ny indretning | |
| IL172541A0 (en) | 2-hydroxymethyl-3,4,5-trihydroxy-1-(4-pentlyoxybenzyl) piperidine as glucosyliceramide synthase (gcs) | |
| IL182538A0 (en) | 1,5-diheterocycle-1h-triazole derivative | |
| IS7901A (is) | 4-(2-Fenýloxýfenýl)-píperidín eða -1,2,3,6-tetrahýdrópýridín afleiður sem serótónín endurupptöku hindrar | |
| NL1030010A1 (nl) | 4-Amino-gesubstitueerde-2-gesubstitueerde-1,2,3,4- tetrahydrochinolineverbindingen. | |
| NO20055002D0 (no) | Benzol[1,2,5]tiadiazolforbindelser | |
| DK1315700T3 (da) | Substituerede 4-phenyl-1-(1-phenylcyclohexyl)-1,2,3,6-tetrahydropyridiner | |
| DE602004005048D1 (de) | 2-methoxymethyl-3-(3,4-dichlorophenyl)-8-azabicyclo ä3.2.1üoctantartrat-salze | |
| TWI315670B (en) | Substituted aryl 1,4-pyrazine derivatives | |
| ATE441647T1 (de) | N-amidderivate von 8-azabicycloä3.2.1üoct-3-yl als ccr1-antagonisten | |
| IS7996A (is) | 4-(2-fenýlsúlfanýl-fenýl)-píperidín afleiður sem serótónín endurupptöku hindrar | |
| DE602005017152D1 (de) | Neue 2,6-diaminopyridin-3-on-derivate | |
| NO20054067D0 (no) | Nye substituerte 2,3-benzodiazepinderivater. | |
| PT1912956E (pt) | Sais metálicos de 2'-(1h-tetrazol-5-ilo)-1,1'-bifenilo-4- carboxaldeído | |
| IS2815B (is) | 2-(1H-indólýlsúlfanýl)-bensýlamínafleiður sem valvís serótónín endurupptökuhindri (SSRI). | |
| ITMI20021328A1 (it) | Nuove piperazine 1,4 - disostituite | |
| EP1681284A4 (en) | AROMATIC POLYAMINE DERIVATIVE |